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Host kinase activity is required for Coxiella burnetii 
parasitophorous vacuole formation
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Coxiella burnetii is the etiologic agent of human Q fever and targets alveolar phagocytic cells 
in vivo wherein the pathogen generates a phagolysosome-like parasitophorous vacuole (PV) for 
replication. C. burnetii displays a prolonged growth cycle, making PV maintenance critical for 
bacterial survival. Previous studies showed that C. burnetii mediates activation of eukaryotic 
kinases to inhibit cell death, indicating the importance of host signaling during infection. In 
the current study, we examined the role of eukaryotic kinase signaling in PV establishment. A 
panel of 113 inhibitors was analyzed for their impact on C. burnetii infection of human THP-1 
macrophage-like cells and HeLa cells. Inhibition of 11 kinases or two phosphatases altered 
PV formation and prevented pathogen growth, with most inhibitor-treated cells harboring 
organisms in tight-fitting phagosomes, indicating kinase/phosphatase activation is required for 
PV maturation. Five inhibitors targeted protein kinase C (PKC), suggesting a critical role for this 
protein during intracellular growth. The PKC-specific substrate MARCKS was phosphorylated 
at 24 h post-infection and remained phosphorylated through 5 days post-infection, indicating 
prolonged regulation of the PKC pathway by C. burnetii. Infection also altered the activation status 
of p38, myosin light chain kinase, and cAMP-dependent protein kinase, suggesting C. burnetii 
subverts numerous phosphorylation cascades. These results underscore the importance of 
intracellular host signaling for C. burnetii PV biogenesis.
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as endocarditis, that exhibits a much higher mortality rate than 
acute disease (Marrie and Raoult, 2002). Although Q fever remains 
somewhat rare in the United States, a large recent outbreak in the 
Netherlands (Delsing and Kullberg, 2008; Schimmer et al., 2009) 
underscores the need to better understand C. burnetii pathogenic 
mechanisms and develop efficacious treatments. Indeed, since 2007, 
over 3500 cases of Q fever have been diagnosed in the Netherlands 
and six deaths reported (Schimmer et al., 2009; Schneeberger 
et al., 2010).
In vivo, C. burnetii initially infects alveolar phagocytic cells and 
directs biogenesis of a phagolysosome-like parasitophorous vacuole 
(PV) in which to replicate (Voth and Heinzen, 2007). C. burnetii 
enters the host cell by passive phagocytosis and resides in a tight-
fitting nascent phagosome during the first 4–6 h post-infection 
(Howe and Mallavia, 2000). After this phagosomal stall, the vacuole 
matures along the endolysosomal pathway and culminates in a PV 
with degradative lysosomal characteristics (Howe et al., 2010). The 
PV lumen is acidic (pH ∼ 5) and contains active hydrolases and 
vacuolar conditions are sufficient to degrade other bacterial cells 
(Howe et al., 2010). The PV acquires membrane via heterotypic 
fusion with endosomes, autophagosomes, and lysosomes while 
expanding to occupy most of the host cell cytoplasm (Voth and 
Heinzen, 2007). In this phagolysosomal PV, C. burnetii replicates 
to high numbers throughout a lengthy infectious cycle (doubling 
time ∼ 11 h; Coleman et al., 2004). Formation and maintenance of 
the PV requires continual C. burnetii protein synthesis as treatment 
with chloramphenicol causes PV collapse and cessation of bacte-
rial replication (Howe et al., 2003). This requirement for de novo 
IntroductIon
Intracellular bacterial pathogens have evolved sophisticated mecha-
nisms to subvert host cell function and establish a protected repli-
cation vacuole. To support intravacuolar growth, these pathogens 
modulate host processes such as vesicular fusion and trafficking, 
cytokine production, and cell survival to avoid delivery to degrada-
tive lysosomes, recognition by the host immune system, and loss of 
a viable host cell, respectively (Knodler et al., 2001; Bhavsar et al., 
2007). Eukaryotic phosphorylation cascades are efficient regulatory 
networks that control processes involved in recognition, uptake, 
and elimination of foreign material such as bacterial pathogens. 
Therefore, host kinases and phosphatases are often at the forefront 
of host–pathogen interactions.
Coxiella burnetii is an intracellular bacterial pathogen that causes 
the zoonosis human Q fever. The pathogen exhibits a global distri-
bution and is primarily spread by contaminated aerosols. Humans 
are typically exposed to infectious organisms through contact with 
infected livestock or their products (Maurin and Raoult, 1999). 
Aside from infrequent abortion in goats, infected animals gener-
ally do not display overt signs of disease, but shed high numbers 
of bacteria into the environment, particularly during parturition. 
In humans, Q fever typically presents as an acute flu-like illness 
characterized by prolonged high fever, with some patients devel-
oping pneumonia or hepatitis (Raoult et al., 2005). Spread from 
the site of acute disease can lead to chronic infections, typically in 
immunocompromised individuals. By mechanisms that are not 
clearly understood, chronic infections can reactivate months or 
years following an initial infection and cause serious illness, such 
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infectivity of virulent C. burnetii necessitates using a higher MOI 
(Voth and Heinzen, 2007). Handling of virulent C. burnetii isolates 
was performed in the CDC-approved biosafety level-3 facility at 
the University of Arkansas for Medical Sciences.
KInase and phosphatase InhIbItor analysIs
THP-1 cells or HeLa cells were cultured in 96-well plates for initial 
assessment of inhibitor treatments. Cells were infected with aviru-
lent C. burnetii in the presence of individual inhibitors at a final 
concentration of 10 μM and all compounds were added at the time 
of infection or 4 hpi. Two inhibitor panels were assessed in this 
study: a kinase inhibitor library containing 80 established pharma-
cologic compounds and a phosphatase inhibitor library containing 
33 compounds (EnzoLife Sciences, Plymouth Meeting, MA, USA) 
in dimethylsulfoxide (DMSO). Medium containing fresh inhibitors 
was replenished every 24 h and PV development was assessed at 
24 and 48 h post-infection (hpi) by light microscopy. Images were 
acquired using a Nikon Ti-U microscope (Nikon, Tokyo, Japan), 
a 40× objective, and a D5-Qi1Mc digital camera. Each inhibitor 
panel was screened during infection three times independently 
using THP-1 cells and once using HeLa cells. Mammalian cell mor-
phology and viability was affected by less than 10% of inhibitors 
as assessed by light microscopy and nuclear staining followed by 
fluorescence microscopy (data not shown).
Fluorescence mIcroscopy
HeLa cells were cultured in 24-well plates on 12-mm cover slips 
and infected with avirulent C. burnetii in the presence or absence 
of a subset of kinase (GF 109203X, SB-203580, H-89, ML-7, or 
KN-93) or phosphatase (pentamidine) inhibitors. At 48 hpi, cells 
were fixed and permeabilized using 100% ice-cold methanol for 
3 min, then incubated for 1 h in phosphate–buffered saline (PBS; 
HyClone Laboratories) containing 0.5% bovine serum albumin 
(BSA; Cell Signaling, Danvers, MA, USA) and 0.05% sodium azide 
(ISC BioExpress, Solon, OH, USA). Cells were incubated with 
PBS–BSA solution containing rabbit anti-C. burnetii and mouse 
anti-CD63 (LAMP-3; BD Biosciences, San Jose, CA, USA) primary 
antibodies to detect bacteria and the PV membrane, respectively, 
for 1 h at room temperature. Primary antibodies were subsequently 
detected using AlexaFlour-594 anti-rabbit and AlexaFluor-488 anti-
mouse secondary antibodies (Invitrogen, Carlsbad, CA, USA) for 
1 h at room temperature. Eukaryotic and bacterial DNA was stained 
with 4′,6-diamidino-2-phenylindole, dilactate (DAPI; Invitrogen). 
Samples were imaged using a Nikon Ti-U microscope with a 60× 
oil immersion objective and images captured with a D5-Qi1Mc 
digital camera (Nikon). Images were analyzed and rendered using 
NIS-Elements software (Nikon).
InhIbItor reversIbIlIty assays
HeLa cells were cultured in 24-well plates on 12-mm cover slips 
and infected with avirulent C. burnetii at an MOI of 10. Infected 
cells were treated with GF 109203X, H-89, ML-7, KN-93, or pen-
tamidine at 10 μM final concentration at the time of infection. 
Inhibitor-containing medium was replaced with medium lacking 
inhibitors at 48 hpi and cells incubated in the absence of inhibitors 
for an additional 48 h to allow potential PV formation. Cells were 
then fixed and processed as described above and PV containing 
protein synthesis presumably involves production and function of 
the pathogen’s Dot/Icm type IV secretion system and associated 
effector proteins (Pan et al., 2008; Voth and Heinzen, 2009a; Voth 
et al., 2009).
The prolonged duration of C. burnetii infection implies that the 
pathogen continually modulates host cell processes. We and others 
recently reported the ability of C. burnetii to potently antagonize 
apoptotic cell death, presumably as a mechanism to sustain the 
host cell. C. burnetii actively inhibits activation of caspase-de-
pendent apoptosis in cultured and primary phagocytic cells and 
non-phagocytic cells. Activation of the intrinsic (mitochondrial-
mediated) and extrinsic (death receptor-mediated) pathways 
is prevented during infection, resulting in potent inhibition of 
host cell death machinery (Luhrmann and Roy, 2007; Voth et al., 
2007). C. burnetii also activates two pro-survival kinases, Akt 
and Erk1/2, an event needed for full protection from apoptosis 
(Voth and Heinzen, 2009b). Akt and Erk1/2 phosphorylation is 
sustained through at least 72 h post-infection, a time at which the 
PV is filling with replicating organisms. Interestingly, inhibition 
of Akt or Erk1/2 does not have an obvious deleterious effect on 
PV formation, only C. burnetii’s ability to antagonize host cell 
death. Although many intracellular pathogens modulate host 
kinase cascades, the scope of C. burnetii signaling regulation is 
poorly understood.
In the current study, we probed the role of host kinases and 
phosphatases in C. burnetii PV formation and found that multiple 
signaling proteins regulate infection. Numerous kinases, includ-
ing protein kinase C (PKC) and cAMP-dependent protein kinase 
(PKA), promote PV development as cells infected in the presence 
of distinct inhibitors do not support vacuole formation or bacte-
rial growth. Additionally, p38, myosin light chain kinase (MLCK), 
PKA, and PKC are activated during intracellular growth, suggesting 
C. burnetii regulates numerous host pathways during infection. 
Collectively, the current results underline the importance of signal-
ing pathway modulation by C. burnetii for PV establishment.
materIals and methods
mammalIan cell culture and C. burnetii
THP-1 human monocytes (TIB-202; American Type Culture 
Collection, Manassas, VA, USA) and HeLa (human epithelioid car-
cinoma) cells (CCL-2; ATCC) were maintained at 37°C and 5% CO
2
 
in RPMI 1640 medium containing 10% fetal calf serum (HyClone 
Laboratories, South Logan, UT, USA). Prior to infections, phorbol 
12-myristate 13-acetate (PMA; EMD Biosciences, San Diego, CA, 
USA) was added to medium for 24 h at a final concentration of 
200 nM to induce differentiation into a macrophage-like cell as pre-
viously described (Voth et al., 2007). Medium containing PMA was 
then removed and cell cultures replenished with complete medium 
lacking PMA prior to infections.
Virulent C. burnetii Nine Mile phase I (RSA493) and G (Q212) 
isolates and avirulent Nine Mile phase II (clone 4; RSA439) organ-
isms (generously provided by Dr. Robert Heinzen, Rocky Mountain 
Laboratories, Hamilton, MT, USA) were propagated in Vero 
(African green monkey kidney) cells (CCL-81; ATCC) and puri-
fied as previously described (Coleman et al., 2004). For infections, 
avirulent C. burnetii was used at a multiplicity of infection (MOI) 
of 10 and virulent isolates at an MOI of 100. The lower in vitro 
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to untreated, infected cell cultures. As shown in Table 1, inhibitors 
were categorized as having a negative impact on vacuole formation 
when less than 10% of cells contained typical PV at 48 hpi. Twenty 
kinase and two phosphatase inhibitors antagonized PV forma-
tion (negative effect), while two inhibitors targeting p38 MAPK 
induced abnormal early PV expansion (positive effect; Figure 1). 
Collectively, inhibitors with demonstrable effects on infection tar-
geted 11 kinases and two phosphatases. p38-inhibited cells con-
tained large PV at 24 hpi, a time when PV are not typically apparent 
by phase contrast microscopy in untreated, infected cell cultures 
(Figure 1A). In contrast, inhibition of the remaining kinases and 
phosphatases (Table 1) prevented PV formation (Figure 1B and 
data not shown). In agreement with previous results from our 
laboratory (Voth and Heinzen, 2009b), the phosphatidylinositol-
3-kinase (PI3K) inhibitors wortmannin and LY-294002 and the 
MEK1/2 antagonist U0126 had no obvious impact on PV forma-
tion (data not shown). Inhibitors that caused rapid cell death at 
the concentration tested (<10% of those tested) were not further 
analyzed (data not shown).
replicating bacteria detected using anti-C. burnetii and anti-CD63 
antibodies. Inhibitor effects were considered reversible when cells 
contained PV similar to untreated, infected cells at 48 h post-
washout.
Immunoblot analysIs
THP-I cells were infected with virulent or avirulent C. burnetii iso-
lates for 3–120 h, then harvested by lysis in buffer containing 50 mM 
Tris, 5 mM EDTA, and 1% sodium dodecyl sulfate (SDS) followed 
by 10 passages through a 21-gage needle. The detergent- compatible 
DC protein assay (Bio-Rad, Hercules, CA, USA) was used to deter-
mine total protein concentration in each lysate. Ten micrograms 
of total protein was separated by 10% SDS-polyacrylamide gel 
electrophoresis and transferred to a 0.2 μm PVDF membrane 
(Bio-Rad). After transfer, membranes were incubated for 1 h at 
room temperature in Tris–buffered saline (TBS; 150 mM NaCl, 
100 mM Tris–HCl, pH 7.6) containing 0.1% Tween-20 and 5% non-
fat milk. After blocking, membranes were incubated with rabbit 
polyclonal antibodies directed against phosphorylated PKA sub-
strates, PKC substrates, MARCKS, p38, or MLC2 (Cell Signaling) in 
TBS-Tween-20 containing 5% BSA at 4°C overnight. Lysates were 
probed for β-tubulin as a loading control using mouse monoclonal 
antibody clone SAP.4G5 (Sigma-Aldrich, St. Louis, MO, USA). 
Reacting proteins were detected with anti-rabbit or anti-mouse 
secondary antibodies conjugated to horseradish peroxidase (Cell 
Signaling) and observed by enhanced chemiluminescence using 
Femto reagent (Pierce, Rockford, IL, USA) following exposure to 
film. Immunoblot images were acquired using a Fluorchem FC2 
gel documentation system (Alpha Innotech Corp., San Leandro, 
CA, USA).
PKA and PKC activity was assessed by probing phosphorylation 
of a panel of downstream substrates. These assays were performed 
using rabbit polyclonal antibodies (Cell Signaling) that recognize 
proteins phosphorylated at distinct serine or threonine residues. 
For PKA, this antibody recognizes proteins with an arginine 3 posi-
tions upstream of the phosphorylated serine or threonine residue. 
The PKC antibody recognizes proteins with phosphorylated serine 
residues surrounded by arginine and lysine residues.
results
host KInases and phosphatases are Involved In C. burnetii pv 
FormatIon
Because C. burnetii subverts host signaling to control apoptotic 
cell death, we predicted the pathogen would also regulate distinct 
pathways to promote generation of its vacuolar niche. To assess 
host signaling pathways involved in PV biogenesis, we examined 
vacuole development in the presence of individual mammalian 
kinase or phosphatase inhibitors. For these studies, we used dif-
ferentiated THP-1 human macrophage-like cells and HeLa (human 
epithelial) cells, which are reliable models of C. burnetii–host cell 
interactions (Voth et al., 2007; Voth and Heinzen, 2009b). THP-1 
or HeLa cells were infected with avirulent C. burnetii for 48 h in 
the presence of individual inhibitors from a panel of 113 well-char-
acterized compounds. C. burnetii directs the synthesis of a large 
replication compartment easily visible by light microscopy (Voth 
and Heinzen, 2007). Thus, we examined  inhibitor-treated cells by 
light microscopy for the presence of prototypical PV as compared 
Table 1 | Inhibitors altering PV formation.
Inhibitor Host target
PosITIVe eFFecT
SB-203580 p38 MAPK
SB-202190 p38 MAPK
NegaTIVe eFFecT
GF 109203X PKC
Ro 31-8220 PKC
Sphingosine PKC
Palmitoyl-dl-carnitine Cl PKC
Rottlerin PKC δ
Lavendustin A EGFRK
RG-14620 EGFRK
Tyrphostin AG 1478 EGFRK
BML-265 EGFRK
Tyrphostin 9 PDGFRK
AG-1296 PDGFRK
PP1 Src family
AG-879 NGFRK
H-89 PKA
KN-93 CaMKII
ML-7 MLCK
ML-9 MLCK
ZM 449829 JAK-3
Indirubin-3′-monoxime GSK-3β
Kenpaullone GSK-3β
Pentamidine PRL1
Gossypol PP2B
CaMKII, calmodulin kinase II; EGFRK, epidermal growth factor receptor kinase; 
GSK-3β, glycogen synthase kinase-3β; JAK-3, janus associated kinase-3; MAPK, 
mitogen activated protein kinase; MLCK, myosin light chain kinase; NGFRK, 
neuronal growth factor receptor kinase; PDGFRK, platelet derived growth factor 
receptor kinase; PKA, protein kinase A; PKC, protein kinase C; PP2B, protein 
phosphatase 2B; PRL1, phosphatase of regenerating liver 1.
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examples. Hence, in inhibitor-treated cells, C. burnetii trafficked 
to a vacuole with characteristics that should support growth but 
was unable to replicate. Conversely, infected cells treated with 
p38 inhibitors housed replicating C. burnetii in unusually large 
CD63-positive vacuoles (Figure 2). However, uninfected cells 
treated with p38 inhibitors did not contain large vacuoles, indi-
cating the effects of these compounds were specific to infected 
cells (data not shown). Similar results were obtained using THP-1 
cells (data not shown).
InhIbItIon oF prl1, pKc, pKa, and mlcK Is reversIble
Our inhibitor-based screen suggested that host kinases and 
phosphatases are intimately involved in prototypical PV matu-
ration. We next analyzed the reversibility of the observed inhibi-
tor effects to determine whether the inhibitors exerted direct 
cytotoxic effects on C. burnetii. PRL1, PKC, PKA, MLCK, and 
CaMKII inhibitors were removed from infected HeLa cells at 
48 hpi and cells incubated an additional 48 h to allow potential 
InhIbItor-treated cells harbor non-replIcatIng organIsms In 
phagolysosome-lIKe compartments
The C. burnetii PV exhibits characteristics strikingly similar 
to host phagolysosomes (Voth and Heinzen, 2007; Howe et al., 
2010). Indeed, the PV is a hydrolytic, degradative compartment, 
and pathogen metabolism is activated at acidic pH (pH ∼ 5) 
where replication ensues, making vacuole maturation critical 
for intracellular growth. Therefore, we examined the localiza-
tion of C. burnetii in inhibitor-treated cells to determine if the 
pathogen was precluded from entry into the cell and transit to 
a phagolysosome-like compartment. HeLa cells were infected 
in the presence of individual inhibitors for 48 h, then processed 
for fluorescence microscopy. Aside from p38-inhibited cells, all 
inhibitor-treated cells contained individual bacteria in tight-
fitting, phagolysosome-like compartments (Figure 2 and data 
not shown) as evidenced by CD63 (LAMP-3) labeling, which 
is commonly used to identify mature PV (Howe et al., 2010). 
PRL1-, PKC-, PKA-, and CaMKII-inhibited cells are shown as 
FIgure 1 | Host kinases and phosphatases are involved in prototypical PV 
formation. HeLa cells were infected for 24 h (a) or 48 h (B) with C. burnetii in 
the presence of p38 (SB-203580), PKC (GF 109203X), PRL1 (pentamidine), or 
PP2B (gossypol) inhibitors and visualized by phase contrast microscopy. Typical 
phase translucent PV are indicated by red arrows (B). p38 inhibitors dramatically 
enhanced PV development [(a) right panel, arrowheads] at early times 
post-infection while PKC, PRL1, and PP2B inhibitors prevented vacuole 
formation (B). Control = infected, untreated cells.
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C. burnetii InFectIon Induces dIFFerentIal phosphorylatIon oF 
euKaryotIc KInases and downstream substrates
Due to the negative effects of several kinase inhibitors on PV for-
mation (Table 1), we predicted that C. burnetii might activate 
a distinct panel of kinases during normal infection. To test this 
hypothesis, THP-1 cells were infected up to 4 days in the absence 
of inhibitors and lysates probed for phosphorylated forms of indi-
vidual kinases at distinct times post-infection. Phosphorylation is 
a reliable indicator of kinase activation status and is required for 
regulation of downstream target activity. As shown in Figure 4, 
C. burnetii infection causes differential phosphorylation of p38 
PV formation. As shown in Figure 3, when PRL1, PKC, PKA, and 
MLCK inhibitors were removed from infected cells, PV matura-
tion ensued, with CD63-positive vacuoles present at 48 h post-
washout. Additionally, these newly expanded vacuoles contained 
increasing numbers of replicating C. burnetii. In contrast, the 
CaMKII antagonist KN-93 appeared to exert a toxic effect on 
C. burnetii, as evidenced by a lack of expanded PV at 48 h post-
washout (Figure 3). These results further suggest that numerous 
signaling proteins, including PRL1, PKC, PKA, and MLCK are 
involved in PV maturation events and do not have bactericidal 
effects on C. burnetii.
FIgure 2 | Inhibitor-treated cells harbor C. burnetii in cD63-positive 
compartments. HeLa cells were infected with C. burnetii for 48 h in the presence 
of the indicated kinase or phosphatase inhibitors. Cells were then processed for 
fluorescence microscopy. A primary antibody recognizing CD63 was used to 
confirm the phagolysosomal nature of the PV, anti-C. burnetii antibody was used 
to detect bacteria, and DAPI was used to stain DNA. Colors are indicated in the 
figure. Cells treated with PRL1 (pentamidine), PKC (GF 109203X), PKA (H-89), or 
CaMKII (KN-93) inhibitors housed organisms in tight-fitting phagolysosome-like 
compartments, whereas p38-inhibited cells contained replicating organisms in 
abnormally enlarged PV. Control = infected, untreated cells.
FIgure 3 | Kinase and phosphatase antagonists reversibly inhibit PV 
formation and C. burnetii growth. HeLa cells were infected with C. burnetii for 
48 h in the presence of the indicated kinase inhibitors, then inhibitors were 
removed from cells for an additional 48 h. At 48 h post-washout, cells were 
processed for fluorescence microscopy using anti-CD63 antibody (green) to 
detect PV and anti-C. burnetii antibody (red) to detect bacteria. DAPI was used 
to stain host and bacterial DNA (blue). Following washout, CD63-positive PV 
formed in cells previously treated with PRL1 (pentamidine), PKC (GF 109203X), 
PKA (H-89), or MLCK (ML-7) inhibitors, indicating these kinases are involved in 
PV formation and are not directly toxic to C. burnetii. In contrast, washout of 
KN-93 did not allow PV expansion or bacterial replication, indicating the effects 
of this inhibitor are not reversible. Control = infected, untreated cells.
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C. burnetii trIggers sustaIned pKc actIvatIon
Five inhibitors in our directed screen targeted PKC, with one 
compound specifically antagonizing PKC-δ, suggesting that 
C. burnetii requires PKC activity for PV establishment. Twelve 
PKC isoforms have been described and are regulated via phos-
phorylation (Reyland, 2009). Due to the complexity of isoform 
activation, we probed total PKC activity during infection by moni-
toring phosphorylation of downstream substrates (Figure 6A). 
THP-1 cells were infected for differing periods of time and total 
cell lysates subjected to immunoblot analysis using an antibody 
to detect PKC substrates phosphorylated on serine or threonine 
residues. By 24 hpi, a substantial overall increase in total PKC sub-
strate phosphorylation was evident, indicative of kinase activation 
(Figure 6A). Furthermore, phosphorylation of myristoylated PKC 
substrate (MARCKs) was sustained through 5 days post-infection 
(Figure 6B), indicating prolonged perturbation of the PKC path-
way by C. burnetii during infection.
The experiments described above were performed using avirulent 
C. burnetii organisms in phase II producing truncated lipopolysac-
charide (LPS; Hackstadt, 1986). Accumulating studies demonstrate 
that this isolate is a reliable model of C. burnetii intracellular activ-
ity (Voth et al., 2007; Vazquez and Colombo, 2009; Howe et al., 
2010). However, it is also important to assess conditions that alter 
PV biogenesis in the context of a virulent C. burnetii infection. 
and myosin light chain-2 (MLC-2), which is the downstream tar-
get of MLCK. Specifically, levels of phosphorylated p38 increased 
over those of uninfected cells at 2 hpi (Figure 4A), then declined 
to near basal level between 48 and 72 hpi similar to previous 
results (Voth and Heinzen, 2009b). MLC-2 was also phosphor-
ylated by 3 hpi; however, levels continued to increase throughout 
infection (Figure 4B).
As shown above (Table 1; Figure 2), the PKA inhibitor H-89 
completely negated PV formation. Therefore, we predicted that 
PKA activation is essential for PV biogenesis and C. burnetii growth. 
To assess kinase activity, we examined the profiles of downstream 
substrates phosphorylated on PKA-specific serine or threonine 
residues during a time course of C. burnetii infection (Figure 5). 
This is a commonly used method for assessing overall PKA activ-
ity and identifying novel downstream targets. As shown in Figure 
5, phosphorylation levels of three PKA substrates substantially 
decreased by 48–72 hpi. Conversely, four proteins exhibited 
increased phosphorylation at later times of infection (24–96 hpi), 
suggesting C. burnetii engages the PKA pathway at different stages 
of intracellular growth for controlled regulation of this versatile 
signaling cascade.
FIgure 4 | C. burnetii induces differential phosphorylation of p38 and 
MLc-2. C. burnetii-infected THP-1 cells were harvested at the indicated times 
and equal amounts of total lysate protein subjected to immunoblot analysis 
using phosphorylation-specific antibodies to detect the proteins designated in 
the figure. (a) Increased p38 phosphorylation was observed at 2 hpi, then 
decreased to basal level by 48–72 hpi. (B) MLC-2 phosphorylation levels 
increased above those of uninfected cells at 3 hpi and levels continued to 
increase through 72 hpi, indicating prolonged kinase activation. Tubulin is 
included as a loading control. C = uninfected cells.
FIgure 5 | Protein kinase a is differentially activated during C. burnetii 
infection. Equal amounts of total lysate protein from THP-1 cells infected for 
the indicated times were analyzed by immunoblotting for PKA substrates 
phosphorylated at distinct serine or threonine residues, indicative of overall 
kinase activity. Molecular weight is given on the left of the blot. Asterisks 
represent proteins with increased phosphorylation levels at 24–96 hpi and 
circles denote proteins with decreased phosphorylation levels after 48 hpi. At 
least seven PKA substrates showed altered phosphorylation levels during 
infection, with increased phosphorylation of three proteins sustained through 
96 hpi. C = uninfected cells.
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Bacterial pathogens commonly usurp host signaling to influ-
ence infection events for the benefit of the pathogen (Bhavsar 
et al., 2007). One conserved bacterial strategy is subversion of host 
apoptosis to antagonize cell death and/or promote proliferation, 
providing a viable niche for replication. For example, Salmonella 
typhimurium activates the host pro-survival kinase Akt during early 
stages of epithelial cell infection (Knodler et al., 2005). Additionally, 
Mycobacterium tuberculosis alters PKC activity during Schwann cell 
infection, leading to increased proliferation throughout a long 
infectious cycle (Tapinos and Rambukkana, 2005). Moreover, C. 
burnetii potently antagonizes macrophage apoptosis in part by trig-
gering sustained activation of Akt and Erk1/2 (Luhrmann and Roy, 
2007; Voth et al., 2007; Voth and Heinzen, 2009b).
Apart from apoptosis, intracellular pathogens also utilize host 
signaling for cellular entry, alteration of cytokine production, and 
regulation of the host cell cycle (Tse et al., 2002; Buchholz and 
Stephens, 2007).Conversely, the role of eukaryotic kinases and 
phosphatases in pathogen vacuole formation has not been eluci-
dated. Pharmacologic inhibitor-based screens provide a directed 
approach to identify pathogen virulence mechanisms and host 
proteins involved in infection. For example, a recent inhibitor-
based study showed that Listeria monocytogenes engages multiple 
host pathways to provide a suitable environment for replication 
(Lieberman and Higgins, 2009). Interestingly, this study impli-
cated a role for PKC in L. monocytogenes infection, similar to our 
current results for C. burnetii. Inhibitor-based screens have also 
Therefore, THP-1 cells were infected with one of two virulent C. 
burnetii pathotypes in phase I producing full-length LPS (Hackstadt, 
1986) and lysates probed for MARCKs phosphorylation indicative 
of PKC activity. Specifically, the Nine Mile (acute disease) and G 
(chronic endocarditis) isolates were analyzed for potential patho-
type-specific responses. As shown in Figure 6C, MARCKs phos-
phorylation increased at 2–24 hpi with virulent isolates and levels 
remained elevated above those of uninfected cells through 72 hpi, 
corresponding to that observed during avirulent C. burnetii infec-
tion. These results suggest PKC activation is a conserved event dur-
ing C. burnetii infection.
dIscussIon
Here, we demonstrate that 13 eukaryotic phosphorylation-based 
signaling components participate in biogenesis of the C. burnetii 
PV. During infection, activity of four kinases substantially increases 
and inhibition of individual kinases or phosphatases prevents PV 
formation. Vacuole development and maintenance is essential for 
replication of many intracellular bacterial pathogens (Brumell and 
Scidmore, 2007; Deretic, 2008; Isberg et al., 2009).To date, pathogen 
replication vacuole studies have appropriately focused on the role of 
fusogenic components such as Rab and SNARE proteins (Brumell 
and Scidmore, 2007), which are essential for membrane fusion and 
phagosome maturation in eukaryotic cells. Results from the current 
study suggest a major role for host kinase-dependent signaling in 
generation of bacterial growth compartments.
FIgure 6 | C. burnetii infection elicits prolonged PKc activation. THP-1 
cells were infected with C. burnetii for the indicated time periods, harvested, 
and equal amounts of total lysate protein subjected to immunoblot analysis. 
Phosphorylation of total PKC substrates and MARCKs were used as 
readouts of PKC activity. Molecular weight is provided in (a). Increased PKC 
substrate phosphorylation was observed through 96 hpi (a) and MARCKs 
phosphorylation was sustained through 120 hpi (B). (c) Virulent C. burnetii 
isolates activate PKC.THP-1 cells were infected with the C. burnetii Nine 
Mile or G isolates for the indicated time periods, harvested, and equal 
amounts of total protein subjected to immunoblot analysis to detect 
phosphorylated MARCKs. Cells infected with C. burnetii Nine Mile or G 
contained increased levels of phosphorylated MARCKs, indicating these 
organisms activate PKC during intracellular growth. Tubulin levels are shown 
as loading controls. C = uninfected cells.
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ectopically expressed in eukaryotic cells (Voth et al., 2009). However, 
whether AnkN and/or AnkO interact with PKC or another host 
protein(s) remains to be determined.
C. burnetii modulates PKC activity during infection as evidenced by 
downstream substrate phosphorylation profiles. Total PKC substrate 
phosphorylation increases at 24 hpi, indicating a post-phagocytosis 
role for the kinase. In agreement with this finding, the PKC-specific 
substrate MARCKs is phosphorylated throughout infection (up to 
5 dpi), indicating prolonged manipulation of this signaling cascade 
during intracellular growth. These sustained effects are similar to our 
previous results regarding prolonged activation of the pro-survival 
kinases Akt and Erk1/2 (Voth and Heinzen, 2009b).
Currently, little is known regarding distinct mechanisms by 
which virulent C. burnetii causes Q fever and avirulent bacteria 
are cleared from immunocompetent hosts. However, inside a 
host cell, virulent and avirulent C. burnetii traffic to similar, if not 
identical, compartments. A recent study showed that phase I and 
phase II isolate PV exhibit similar development kinetics and fuse 
with phagolysosomes (Howe et al., 2010). Both vacuoles are also 
degradative as evidenced by destruction of Escherichia coli in the 
PV, further confirming that the avirulent C. burnetii model is rep-
resentative of a virulent isolate infection. In agreement with these 
findings, both avirulent and virulent C. burnetii, including acute 
and chronic disease isolates, trigger sustained activation of PKC. 
Furthermore, virulent C. burnetii isolates activate p38 with similar 
kinetics to avirulent phase II organisms (Voth, unpublished results). 
These results indicate that many C. burnetii signaling activities are 
conserved among pathotypes.
The third category of kinases involved in PV generation includes 
proteins that participate in host calcium and cAMP signaling. 
Inhibition of PKA, CaMKII, or MLCK results in defective vacuole 
expansion and decreased bacterial replication. PKA is regulated by 
cAMP levels and controls activation of downstream components 
including CREB, GSK-3β, and nuclear factor-κB (Pearce et al., 2010). 
Nothing is known regarding C. burnetii interaction with PKA or sec-
ond messenger molecules. However, other intracellular pathogens, 
such as Brucella suis, modulate PKA activity during infection (Gross 
et al., 2003). CaMKII and MLCK are calmodulin-activated kinases 
involved in cellular functions such as cytoskeletal regulation (Bayer 
and Schulman, 2001). CaMKII has been implicated in M. tuberculosis 
infection whereby the kinase controls delivery of infectious organisms 
to lysosomes where they are destroyed (Malik et al., 2001). It is unlikely 
that CaMKII or MLCK are solely needed for delivery of C. burnetii to 
a phagolysosome, as the pathogen resides in CD63-positive vacuoles 
following inhibitor treatment. However, the PV decorates with actin 
and actin-related proteins (Aguilera et al., 2009); thus, CaMKII and 
MLCK may regulate PV expansion and/or trafficking in the cell.
One inhibitor tested, pentamidine, targets the phosphatase 
PRL1 and has recently been employed to examine the mechanism 
of C. burnetii intron activity. Minnick et al. (2010) showed that 
pentamidine reduces pathogen growth in host cells by ∼73%. 
Pentamidine is an anti-fungal and anti-protozoal agent used to 
treat Pneumocystis carinii and trypanosome infections (Soeiro 
et al., 2008; Cushion and Walzer, 2009) and is predicted to act on 
two C. burnetii self-splicing group I introns (Minnick et al., 2010). 
Likewise, our current results show that pentamidine antagonizes 
been used to uncover host processes subverted by Vibrio cholerae 
(Hung et al., 2005), Toxoplasma gondii (Carey et al., 2004), and 
Pseudomonas aeruginosa (De La Fuente et al., 2006), highlight-
ing the utility of chemical inhibitor screening in host–pathogen 
interaction  studies. Moreover, recent siRNA-based screens have 
uncovered roles for host signaling in the intracellular lifestyles 
of M. tuberculosis (Jayaswal et al., 2010), Brucella melitensis, and 
Brucella abortus (Qin et al., 2008).
It is important to note that pharmacologic inhibitors can alter 
the activity of proteins other than their intended target. For exam-
ple, Rottlerin inhibits PKC-δ, but can also affect PKC-α, -β, and 
-γ and CaMKII activity (Gschwendt et al., 1994). Thus, we used 
the inhibitor panel in this study solely as a tool to implicate host 
pathway involvement in PV biogenesis, not as definitive proof of 
kinase importance. This panel allowed us to generate a number 
of hypotheses about the role of host signaling during C. burnetii 
infection and directed our assessments of p38, MLCK, PKA, and 
PKC activity, which indicate distinct cascades are manipulated 
during infection. However, the absolute specificity of each inhibi-
tor during infection has not been confirmed for the compounds 
in our panel.
Two contrasting effects are observed when C. burnetii-infected 
cells are incubated with kinase/phosphatase inhibitors. First, 
cells treated with p38 antagonists harbor bacteria in abnormally 
expanded CD63-positive vacuoles at 24–48 hpi, suggesting the 
kinase regulates early PV formation events. Second, inhibition of 10 
kinases or 2 phosphatases impedes PV development. Interestingly, 
inhibitor treatment does not prevent delivery of C. burnetii to its 
favored phagolysosome-like compartment as single organisms are 
housed in tight-fitting CD63-positive vacuoles, but fail to replicate. 
These results suggest host signaling is needed for PV maturation 
steps including membrane acquisition and expansion and is not 
simply required for phagocytosis of C. burnetii or phagosome–
lysosome fusion. Furthermore, cells treated with distinct inhibitors 
4 h after uptake of C. burnetii contain small PV with non-replicating 
organisms (data not shown). Importantly, these adverse effects are 
reversible, with PV expanding after inhibitor removal in most cases, 
indicating kinases are required for PV biogenesis and inhibitors are 
not cytotoxic to C. burnetii.
Three major classes of kinases are involved in PV generation. 
First, seven inhibitors target the cell surface receptor kinases EGFRK, 
PDGFRK, and NGFRK. C. burnetii interactions with these proteins 
likely occur during entry into a host cell. Thus, we did not study these 
kinases further as our goal was to identify components required 
for PV development following phagocytosis. Second, five inhibitors 
target PKC, a versatile protein with diverse activities in eukaryotic 
systems. Twelve PKC isoforms have been described, with each regu-
lating distinct events via phosphorylation of downstream targets 
including MARCKs and GSK-3β (Gonelli et al., 2009). PKC also 
localizes to phagosomal compartments (Ng Yan Hing et al., 2004; 
Parent et al., 2009). Thus, it is intriguing to predict that C. burnetii 
proteins may interact with PKC at the PV membrane. Intracellular 
pathogens often target their proteins to the vacuolar membrane 
surface for efficient interaction with host proteins (Ragaz et al., 2008; 
Ninio et al., 2009). Indeed, C. burnetii produces two secreted effector 
proteins, AnkN and AnkO, that decorate the PV membrane when 
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in our study have been targeted in clinical trials as disease thera-
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